inflammasomedriven
Inflammasomedriven refers to biological processes and pathological states in which inflammasome signaling is the central driver of inflammation. Inflammasomes are cytoplasmic multiprotein complexes that sense microbial, environmental, and endogenous danger signals. Upon activation, they recruit and activate caspase-1, which processes the proinflammatory cytokines interleukin-1 beta (IL-1β) and interleukin-18 (IL-18) and promotes pyroptotic cell death through gasdermin D. The result is a rapid, local or systemic inflammatory response.
Although several inflammasome types exist (such as NLRP3, NLRC4, AIM2), NLRP3 is the most extensively studied
Inflammasomedriven inflammation contributes to a range of diseases, including autoinflammatory syndromes such as CAPS, gout, atherosclerosis,
Therapeutic approaches aim to dampen inflammasome activity or its cytokines. Examples include inhibitors targeting NLRP3 (in
As a description, inflammasomedriven emphasizes the central role of inflammasome pathways in initiating or sustaining inflammation,